Your browser doesn't support javascript.
loading
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study.
Taylor, Matthew H; Betts, Courtney B; Maloney, Lauren; Nadler, Eric; Algazi, Alain; Guarino, Michael J; Nemunaitis, John; Jimeno, Antonio; Patel, Priti; Munugalavadla, Veerendra; Tao, Lin; Adkins, Douglas; Goldschmidt, Jerome H; Cohen, Ezra E W; Coussens, Lisa M.
Afiliación
  • Taylor MH; Division of Hematology and Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Betts CB; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Maloney L; Division of Hematology and Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Nadler E; Department of Cell, Developmental, and Cancer Biology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon.
  • Algazi A; Baylor University Medical Center, Dallas, Texas.
  • Guarino MJ; University of California San Francisco, San Francisco, California.
  • Nemunaitis J; Helen F. Graham Cancer Center and Research Institute, Newark, Delaware.
  • Jimeno A; University of Toledo College of Medicine and Life Sciences, and ProMedica Health System, Toledo, Ohio.
  • Patel P; University of Colorado Cancer Center, Denver, Colorado.
  • Munugalavadla V; AstraZeneca, South San Francisco, California.
  • Tao L; AstraZeneca, South San Francisco, California.
  • Adkins D; AstraZeneca, South San Francisco, California.
  • Goldschmidt JH; Washington University School of Medicine, St. Louis, Missouri.
  • Cohen EEW; Blue Ridge Cancer Care, Blacksburg, Virginia.
  • Coussens LM; University of California San Diego, Moores Cancer Center, La Jolla, California.
Clin Cancer Res ; 28(5): 903-914, 2022 Mar 01.
Article en En | MEDLINE | ID: mdl-34862248

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Células Escamosas de Cabeza y Cuello / Neoplasias de Cabeza y Cuello Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos